|
|
|
|
Investor
Relations > Introduction
............................................................................................................................................................................................................................................................................................................
|
|
|
Introduction
|
|
Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer, central nervous system disorders and other unmet medical needs.
Our mission is to impact the health and wellness of patients with life-threatening and life-debilitating diseases.
Recent News ........... [more]
|
February 01, 2010
|
|
Rexahn Pharmaceuticals to Present at the 12th Annual Bio CEO & Investor Conference |
|
January 19, 2010
|
|
Rexahn Pharmaceuticals Granted European Patent for Anti-cancer Compound RX-3117 |
|
|
